A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

November 4, 2019

Study Completion Date

November 16, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-906

TAK-906 capsule.

DRUG

Rifampin

Rifampin infusion.

Trial Locations (1)

Celerion, Lincoln